Merit Medical Systems, Inc.

NasdaqGS:MMSI Stock Report

Market Cap: US$4.3b

Merit Medical Systems Management

Management criteria checks 2/4

Merit Medical Systems' CEO is Fred Lampropoulos, appointed in Jul 1987, has a tenure of 36.75 years. total yearly compensation is $10.05M, comprised of 18.8% salary and 81.2% bonuses, including company stock and options. directly owns 1.99% of the company’s shares, worth $85.31M. The average tenure of the management team and the board of directors is 7 years and 4.3 years respectively.

Key information

Fred Lampropoulos

Chief executive officer

US$10.1m

Total compensation

CEO salary percentage18.8%
CEO tenure36.8yrs
CEO ownership2.0%
Management average tenure7yrs
Board average tenure4.3yrs

Recent management updates

Recent updates

Merit Medical Systems, Inc. (NASDAQ:MMSI) Not Lagging Market On Growth Or Pricing

Apr 16
Merit Medical Systems, Inc. (NASDAQ:MMSI) Not Lagging Market On Growth Or Pricing

When Should You Buy Merit Medical Systems, Inc. (NASDAQ:MMSI)?

Apr 02
When Should You Buy Merit Medical Systems, Inc. (NASDAQ:MMSI)?

Merit Medical Systems: Solid Performer, Fully Valued

Mar 03

Analyst Estimates: Here's What Brokers Think Of Merit Medical Systems, Inc. (NASDAQ:MMSI) After Its Full-Year Report

Mar 02
Analyst Estimates: Here's What Brokers Think Of Merit Medical Systems, Inc. (NASDAQ:MMSI) After Its Full-Year Report

We Ran A Stock Scan For Earnings Growth And Merit Medical Systems (NASDAQ:MMSI) Passed With Ease

Feb 05
We Ran A Stock Scan For Earnings Growth And Merit Medical Systems (NASDAQ:MMSI) Passed With Ease

The Returns At Merit Medical Systems (NASDAQ:MMSI) Aren't Growing

Jan 23
The Returns At Merit Medical Systems (NASDAQ:MMSI) Aren't Growing

What You Can Learn From Merit Medical Systems, Inc.'s (NASDAQ:MMSI) P/E

Dec 18
What You Can Learn From Merit Medical Systems, Inc.'s (NASDAQ:MMSI) P/E

These 4 Measures Indicate That Merit Medical Systems (NASDAQ:MMSI) Is Using Debt Safely

Nov 21
These 4 Measures Indicate That Merit Medical Systems (NASDAQ:MMSI) Is Using Debt Safely

What Is Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Share Price Doing?

Nov 06
What Is Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Share Price Doing?

Estimating The Fair Value Of Merit Medical Systems, Inc. (NASDAQ:MMSI)

Oct 23
Estimating The Fair Value Of Merit Medical Systems, Inc. (NASDAQ:MMSI)

Does Merit Medical Systems (NASDAQ:MMSI) Deserve A Spot On Your Watchlist?

Sep 11
Does Merit Medical Systems (NASDAQ:MMSI) Deserve A Spot On Your Watchlist?

Return Trends At Merit Medical Systems (NASDAQ:MMSI) Aren't Appealing

Aug 13
Return Trends At Merit Medical Systems (NASDAQ:MMSI) Aren't Appealing

Is Now An Opportune Moment To Examine Merit Medical Systems, Inc. (NASDAQ:MMSI)?

Jul 31
Is Now An Opportune Moment To Examine Merit Medical Systems, Inc. (NASDAQ:MMSI)?

Is Merit Medical Systems (NASDAQ:MMSI) A Risky Investment?

Jul 17
Is Merit Medical Systems (NASDAQ:MMSI) A Risky Investment?

Is Now The Time To Put Merit Medical Systems (NASDAQ:MMSI) On Your Watchlist?

Jun 07
Is Now The Time To Put Merit Medical Systems (NASDAQ:MMSI) On Your Watchlist?

Is It Time To Consider Buying Merit Medical Systems, Inc. (NASDAQ:MMSI)?

May 01
Is It Time To Consider Buying Merit Medical Systems, Inc. (NASDAQ:MMSI)?

We Think Merit Medical Systems (NASDAQ:MMSI) Can Manage Its Debt With Ease

Apr 16
We Think Merit Medical Systems (NASDAQ:MMSI) Can Manage Its Debt With Ease

Returns On Capital At Merit Medical Systems (NASDAQ:MMSI) Have Hit The Brakes

Apr 02
Returns On Capital At Merit Medical Systems (NASDAQ:MMSI) Have Hit The Brakes

Is Now The Time To Put Merit Medical Systems (NASDAQ:MMSI) On Your Watchlist?

Mar 01
Is Now The Time To Put Merit Medical Systems (NASDAQ:MMSI) On Your Watchlist?

Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Intrinsic Value Is Potentially 24% Below Its Share Price

Feb 01
Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Intrinsic Value Is Potentially 24% Below Its Share Price

Is Now The Time To Look At Buying Merit Medical Systems, Inc. (NASDAQ:MMSI)?

Jan 12
Is Now The Time To Look At Buying Merit Medical Systems, Inc. (NASDAQ:MMSI)?

Merit Medical Systems (NASDAQ:MMSI) Seems To Use Debt Rather Sparingly

Dec 29
Merit Medical Systems (NASDAQ:MMSI) Seems To Use Debt Rather Sparingly

Here's Why We Think Merit Medical Systems (NASDAQ:MMSI) Is Well Worth Watching

Nov 23
Here's Why We Think Merit Medical Systems (NASDAQ:MMSI) Is Well Worth Watching

A Look At The Intrinsic Value Of Merit Medical Systems, Inc. (NASDAQ:MMSI)

Oct 23
A Look At The Intrinsic Value Of Merit Medical Systems, Inc. (NASDAQ:MMSI)

At US$56.45, Is It Time To Put Merit Medical Systems, Inc. (NASDAQ:MMSI) On Your Watch List?

Oct 11
At US$56.45, Is It Time To Put Merit Medical Systems, Inc. (NASDAQ:MMSI) On Your Watch List?

Merit Medical Systems (NASDAQ:MMSI) Might Have The Makings Of A Multi-Bagger

Sep 28
Merit Medical Systems (NASDAQ:MMSI) Might Have The Makings Of A Multi-Bagger

Merit Medical Systems (NASDAQ:MMSI) Seems To Use Debt Rather Sparingly

Sep 16
Merit Medical Systems (NASDAQ:MMSI) Seems To Use Debt Rather Sparingly

Merit Medical: No Change To Hold Thesis, ROIC Still One To Watch

Sep 09

Should You Be Adding Merit Medical Systems (NASDAQ:MMSI) To Your Watchlist Today?

Aug 10
Should You Be Adding Merit Medical Systems (NASDAQ:MMSI) To Your Watchlist Today?

Calculating The Fair Value Of Merit Medical Systems, Inc. (NASDAQ:MMSI)

Jul 14
Calculating The Fair Value Of Merit Medical Systems, Inc. (NASDAQ:MMSI)

Why Merit Medical Systems, Inc. (NASDAQ:MMSI) Could Be Worth Watching

Jun 29
Why Merit Medical Systems, Inc. (NASDAQ:MMSI) Could Be Worth Watching

We Think Merit Medical Systems (NASDAQ:MMSI) Can Manage Its Debt With Ease

Jun 14
We Think Merit Medical Systems (NASDAQ:MMSI) Can Manage Its Debt With Ease

CEO Compensation Analysis

How has Fred Lampropoulos's remuneration changed compared to Merit Medical Systems's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$10mUS$2m

US$94m

Sep 30 2023n/an/a

US$100m

Jun 30 2023n/an/a

US$90m

Mar 31 2023n/an/a

US$85m

Dec 31 2022US$8mUS$2m

US$75m

Sep 30 2022n/an/a

US$62m

Jun 30 2022n/an/a

US$58m

Mar 31 2022n/an/a

US$48m

Dec 31 2021US$8mUS$2m

US$48m

Sep 30 2021n/an/a

US$43m

Jun 30 2021n/an/a

US$28m

Mar 31 2021n/an/a

US$4m

Dec 31 2020US$8mUS$2m

-US$10m

Sep 30 2020n/an/a

-US$29m

Jun 30 2020n/an/a

-US$30m

Mar 31 2020n/an/a

-US$4m

Dec 31 2019US$5mUS$2m

US$5m

Sep 30 2019n/an/a

US$19m

Jun 30 2019n/an/a

US$39m

Mar 31 2019n/an/a

US$43m

Dec 31 2018US$4mUS$2m

US$42m

Sep 30 2018n/an/a

US$40m

Jun 30 2018n/an/a

US$19m

Mar 31 2018n/an/a

US$18m

Dec 31 2017US$4mUS$1m

US$28m

Compensation vs Market: Fred's total compensation ($USD10.05M) is above average for companies of similar size in the US market ($USD6.66M).

Compensation vs Earnings: Fred's compensation has increased by more than 20% in the past year.


CEO

Fred Lampropoulos (73 yo)

36.8yrs

Tenure

US$10,052,664

Compensation

Mr. Fred P. Lampropoulos has been the President of BioSphere Medical, Inc. since September 2010. He is Founder of Merit Medical Systems, Inc. and has been its Chairman, Chief Executive Officer and Presiden...


Leadership Team

NamePositionTenureCompensationOwnership
Fred Lampropoulos
Founder36.8yrsUS$10.05m1.99%
$ 85.3m
Raul Parra
CFO & Treasurer5.9yrsUS$2.77m0.013%
$ 553.1k
Neil Peterson
Chief Operating Officer2yrsUS$2.71m0.013%
$ 556.5k
Brian Lloyd
Chief Legal Officer & Corporate Secretary8yrsUS$2.66m0.030%
$ 1.3m
Joseph Wright
Chief Commercial Officer8.8yrsUS$2.81m0.060%
$ 2.6m
Jason Treft
Chief Information Officer1.3yrsno datano data
Sarah Comstock
Vice President of Global Communicationsno datano datano data
JoAnne Alkire
Executive Vice President of Global Marketing & Strategyno datano datano data
Michel Voigt
Chief Human Resources Officer3.3yrsno data0%
$ 0
John Knorpp
Chief Regulatory Affairs Officer11.3yrsno datano data
Ricardo Alvarez
Managing Director of Operation Merit Medical Tijuanano datano datano data
Mark Butler
Executive Vice President of Merit Medical EMEAno datano datano data

7.0yrs

Average Tenure

54.5yo

Average Age

Experienced Management: MMSI's management team is seasoned and experienced (7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Fred Lampropoulos
Founder36.8yrsUS$10.05m1.99%
$ 85.3m
Michael McDonnell
Independent Director1.9yrsUS$232.93k0.0053%
$ 226.0k
Aldon Anderson
Independent Director12.4yrsUS$281.01k0.076%
$ 3.3m
David Floyd
Independent Director3.8yrsUS$266.01k0.020%
$ 870.6k
F. Millner
Lead Independent Director8.8yrsUS$320.99k0.048%
$ 2.1m
Laura Kaiser
Independent Director1.9yrsUS$275.99k0.0053%
$ 226.0k
Thomas Gunderson
Independent Director6.9yrsUS$290.99k0.029%
$ 1.3m
Lonny Carpenter
Independent Director3.8yrsUS$281.01k0.018%
$ 780.4k
Lynne Ward
Independent Director4.7yrsUS$283.51k0.010%
$ 442.6k
Stephen Evans
Independent Director2.8yrsUS$266.01k0.0086%
$ 368.3k

4.3yrs

Average Tenure

63.5yo

Average Age

Experienced Board: MMSI's board of directors are considered experienced (4.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.